Association of CTLA-4 (+49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children

Immunological Investigations

Volumn 41, Issue 1, 2012, Pages 28-37

  Mosaad, Youssef M ^a   Elsharkawy, Ashraf A ^a   El Deek, Basem S ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Children; CTLA 4; Egyptian; RFLP; T1D

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA; HEMOGLOBIN A1C; HUMAN INSULIN;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; EGYPT; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; AGE FACTORS; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; EGYPT; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PARENTS; POLYMORPHISM, GENETIC;

EID: 81555212315     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.579215     Document Type: Article

References (41)

1. Abe, T., Takino, H., Yamasaki, H.et al., (1999). CTLA-4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res Clin Pract. Nov;46(2):169-175.
2. American Diabetes Association (2010). Standards of medical care in diabetes-2010. Diabetes Care Jan;33 Suppl 1:S11-S61.
3. Angel, B., Balic, I., Santos, J. L., Codner, E., Carrasco, E., Perez-Bravo, F. (2009). Asociations of the CTLA-4 polymorphisms with type 1 diabetes in a Chilean population: Case-parent design . Diabetes Res Clin Pract. Sep;85(3):e34-36.
4. Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M. C., Polychronakos, C. (2002). A common autoimmunity predisposing signal peptide variant of the cytotoxic Tlymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J. Biol. Chem. Nov 29;277(48):46478-46486.
5. Awata, T., Kurihara, S., Iitaka, M., et al. (1998). Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47:128-129.
6. Balic, I., Angel, B., Codner, E., Carrasco, E., Perez-Bravo, F. (2009). Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum. Immunol. Feb;70(2):116-120.
7. Bottini, N., Vang, T., Cucca, F., Mustelin, T. (2006). Role of PTPN22 in type 1 diabetes and other autoimmune disease. Semin. Immunol. Aug;18(4):207-213.
8. Donner, H., Rau, H., Walfish, P. G., et al. (1997). CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease & type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. Jan;82(1):143-146.
9. Doyle, E. A., Weinzimer, S. A., Steffen, A. T., et al. (2004). A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27:1554-1558.
10. Fife, B. T., Bluestone, J. A. (2008). Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev. Aug; 224:166-182.
11. Gregersen, P. K., Behrens, T. W. (2006). Genetics of autoimmune diseases-disorders of immune homeostasis. Nat. Rev. Genet. Dec;7(12):917-928.
12. 4+49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens Feb;69(2):121-127.
13. Hayashi, H., Kusaka, I., Nagasaka, S., et al. (1999). Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus. Clin. Endocrinol. (Oxf). Dec;51(6):793-799.
14. Ide, A., Kawasaki, E., Abiru, N., et al. (2004). Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. Feb;22(1):73-78.
15. Ihara, K., Ahmed, S., Nakao, F., et al. (2001). Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics Aug;53(6):447-454.
16. Jonson, C. O., Lernmark, A., Ludvigsson, J., Rutledge, E. A., Hinkkanen, A., Faresjo, M. (2007). The importance of CTLA-4 polymorphism and human leukocyte antigen school children. Pediatr. Diabetes Aug;8 (4):185-192.
17. Kavvoura, K. F., Ioannidis P. A. (2005). CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a huge review and meta-analysis. Am. J. Epidemiol. Jul 1;162(1):3-16.
18. Kikuoka, N., Sugihara, S., Yanagawa, T., et al. (2001). Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: Analysis of association with HLA genotypes and autoantibodies. Clin. Endocrinol. (Oxf). Nov;55(5):597-603.
19. Korolija, M., Renar, I. P., Hadzija, M., et al. (2009). Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with Type 1 Diabetes in Croatians. Diabetes Res. Clin. Pract. Dec;86(3):e54-57.
20. Kouki, T., Gardine, C. A., Yanagawa, T., Degroot, L. J. (2002). Relation of three polymorphisms of the CTLA-4 gene in patients with Graves disease. J. Endocrinol. Invest. Mar;25(3):208-213.
21. Kouki, T., Sawai, Y., Gardine, C. A., Fisfalen, M. E., Alegre, M. L., DeGroot, L. J. (2000). CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 165:6606-6611.
22. Lee, Y. J., Lo, F. S., Shu, S. G., et al. (2001). The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. Apr;14(4):383-388.
23. Ligers, A., Teleshova, N., Masterman, T., Huang, W. X., Hillert, J. (2001). CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. May;2(3):145-152.
24. Ligers, A., Xu, C., Saarinen, S., Hillert, J, Olerup O. (1999). The CTLA-4 gene is associated with multiple sclerosis. J. Neuroimmunol. 97: 182-190.
25. Maier, L. M., Wicker, L. S. (2005). Genetic susceptibility of type 1 diabetes. Curr. Opin. Immunol. Dec;17(6):601-608.
26. Marron, M. P., Raffel, L. J., Garchon, H. J., et al. (1997). Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA-4 polymorphisms in multiple ethnic groups. Hum Mol Genet. 1997 Aug;6(8):1275-1282.
27. Maurer, M., Loserth, S., Kolb-Mäurer, A., et al. (2002). A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics Apr;54(1):1-8.
28. 4+49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diabetes Res Clin Pract. May;68(2):111-116.
29. Nimri, R., Weintrob, N., Benzaquen, H., et al. (2006). Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Pediatrics 117:2126-2131.
30. Nisticó, L., Buzzetti, R., Pritchard, L. E., et al. (1996). The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. Jul;5(7):1075-1080.
31. Ounissi-Benkalha, H., Polychronakos, C. (2008). The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol. Med. Jun;14(6):268-275.
32. Pankewycz, O. G., Guan, J., Benedict, J. F. (1995). Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocr. Rev. 16(2):164-176.
33. Seidl, C., Donner, H., Fischer, B., et al. (1998). CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 51:62-66.
34. Takara M, Komiya I, Kinjo Y, 22Tomoyose%20T%22%5BAuthor%5D et al. (2000). Association of CTLA-4 gene /G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care Jul;23(7):975-978 .
35. Teft, W., Kirchhof, M., Madrenas, J. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 2006;24:65-97.
36. Turpeinen, H., Laine, A. P., Hermann, R., et al. (2003). A linkage analysis of the CTLA-4 gene region in Finnish patients with type 1 diabetes. Eur. J. Immunogenet. Aug;30(4):289-293.
37. Ueda, H., Howson, J. M., Esposito, L., et al. (2003). Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature May 29;423(6939):506-511.
38. Vaidya, B., Pearce, S. (2004). The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur. J. Endocrinol. May;150(5):619-626.
39. Van der Auwera, B. J., Vandewalle, C. L., Schuit, F. C., et al. (1997). CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin. Exp. Immunol. Oct;110(1):98-103.
40. Yanagawa, T., Hidaka, Y., Guimaraes, V., Soliman, M., DeGroot, L. J. (1995). CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. Jan;80(1):41-45 .
41. Zalloua, P. A., Abchee, A., Shbaklo, H., et al. (2004). Patients with early onset of type 1diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum. Immunol. Jul;65(7):719-724.